Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening (SPIT-LC)
This is a pilot study to test the feasibility of using gene expression from saliva to identify patients with early-stage non-small cell lung cancer (NSCLC).
The primary objective of this study is to compare gene expression profiles from saliva from healthy controls and patients with early-stage non-small cell lung cancer.
To be eligible, patients with non-small cell lung cancer, must not yet have received treatment for their cancer (surgical removal, chemotherapy, or radiation therapy). Health control participants may participate if they meet eligibility criteria listed below.
Eligible enrollees will be asked to submit a one time saliva sample and complete a study questionaire.
Non-Small Cell Lung Cancer
|Study Design:||Observational Model: Case Control|
|Official Title:||Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening|
|Study Start Date:||August 2007|
|Study Completion Date:||July 2008|
|Primary Completion Date:||July 2008 (Final data collection date for primary outcome measure)|
Non-small cell lung cancer patients
Healthy control subjects
Please refer to this study by its ClinicalTrials.gov identifier: NCT00607425
|Principal Investigator:||Glen J Weiss, MD||TGen Clinical Research Services at Scottsdale Healthcare|